Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update Q and A

JCO Oncol Pract. 2022 Nov;18(11):753-755. doi: 10.1200/OP.22.00363. Epub 2022 Aug 10.

Authors

Jennie R Crews¹, Jeffrey J Kirshner², Sarah Temin³

Affiliations

¹ Seattle Cancer Care Alliance, Seattle, WA.
² Hematology/Oncology Associates of Central New York, East Syracuse, NY.
³ American Society of Clinical Oncology, Alexandria, VA.

PMID: 35947811
DOI: 10.1200/OP.22.00363

No abstract available

MeSH terms

Breast
Breast Neoplasms* / drug therapy
Female
Humans
Receptor, ErbB-2 / metabolism

Substances

ERBB2 protein, human
Receptor, ErbB-2